An analysis of 844,108 adults in four countries reclassified obesity using waist measures, waist-to-height ratio, organ function and limitations in daily activities alongside BMI. Excess-adiposity obesity prevalence rose by 3.3–7.4 percentage points across countries, with clinical obesity involving functional impairment accounting for 22.7–31.3% of those classified as obese. Relative to people with neither obesity nor functional impairment, mortality risk was about 69% higher for clinical obesity and 19% higher for preclinical obesity. These are observational associations; whether the new framework improves treatment outcomes needs further testing.